Plain-English translation of NCT04553523 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Hydrus Microstent, a tiny device implanted in the eye during cataract surgery to help lower the pressure inside your eye. If you have open-angle glaucoma and need cataract surgery, this treatment may help improve how well fluid drains from your eye, reducing the need for eye drops.
Many people with glaucoma struggle to control their eye pressure with medications alone, and some need multiple eye drops every day. This treatment aims to give patients another option by working directly inside the eye during surgery they may already need.
You likely qualify if…
You likely don't qualify if…
You would have the tiny implant placed during your cataract surgery. Then you would return for follow-up visits at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months, 18 months, and 24 months after surgery so doctors can check how well the implant is working and monitor your eye pressure and vision.
AI-generated summary from trial data · Aug 10, 2026 · Not medical advice
United States